Bibliography

** Moore JP, Parren PW, Burton DR. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol. 2001 Jul;75(13):5721-9. Review.

Johanson J, Abravaya K, Caminiti W, Erickson D, Flanders R, Leckie G, Marshall E, Mullen C, Ohhashi Y, Perry R, Ricci J, Salituro J, Smith A, Tang N, Vi M, Robinson J. A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. J Virol Methods. 2001 Jun;95(1-2):81-92.

Agwale SM, Robbins KE, Odama L, Saekhou A, Zeh C, Edubio A, Njoku OM, Sani-Gwarzo N, Gboun MF, Gao F, Reitz M, Hone D, Folks TM, Pieniazek D, Wambebe C, Kalish ML. Development of an env gp41-Based Heteroduplex Mobility Assay for Rapid Human Immunodeficiency Virus Type 1 Subtyping. J Clin Microbiol. 2001 Jun;39(6):2110-4.

** Walker BD, Korber BT. Immune control of HIV: the obstacles of HLA and viral diversity. Nat Immunol. 2001 Jun;2(6):473-5. Review.

** Thomson MM, Najera R. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Infect Dis. 2001 Jun 15;32(12):1732-7

Posada D, Crandall KA. Selecting models of nucleotide substitution: an application to human immunodeficiency virus 1 (HIV-1). Mol Biol Evol. 2001 Jun;18(6):897-906.

Gao F, Vidal N, Li Y, Trask SA, Chen Y, Kostrikis LG, Ho DD, Kim J, Oh MD, Choe K,

Salminen M, Robertson DL, Shaw GM, Hahn BH, Peeters M. Evidence of Two Distinct Subsubtypes within the HIV-1 Subtype A Radiation. AIDS Res Hum Retroviruses. 2001 May 20;17(8):675-88.

Hu DJ, Vanichseni S, Mastro TD, Raktham S, Young NL, Mock PA, Subbarao S, Parekh BS, Srisuwanvilai L, Sutthent R, Wasi C, Heneine W, Choopanya K. Viral load differences in early infection with two HIV-1 subtypes. AIDS. 2001 Apr13; 15(6):683-91.

Hara T, Yoshino N, Takayama N, Minamitani M, Naganawa S, Ohkubo H, Takizawa M, Izumi Y, Kantake M, Suzuki S, Takano M, Kita T, Totani R, Nagai Y, Honda M, Nakasone T. Presence of multiple HIV type 1 subtypes among mothers and children in Japan. AIDS Res Hum Retroviruses. 2001 Apr 10;17(6):569-75.

Parry JV, Murphy G, Barlow KL, Lewis K, Rogers PA, Belda FJ, Nicoll A, McGarrigle C, Cliffe S, Mortimer PP, Clewley JP. National surveillance of HIV-1 subtypes for England and Wales: design, methods, and initial findings. J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):381-8.

Frater AJ, Chaput CC, Beddows S, Weber JN, McClure MO. Simple detection of point mutations associated with HIV-1 drug resistance. J Virol Methods. 2001 Apr;93(1-2):145-56.

Ernest I, Alexandre I, Zammatteo N, Herman M, Houbion A, De Leener F, Fransen K, van der Groen G, Remacle J. Quantitative assay for group M (subtype A-H) and group O HIV-1 RNA detection in plasma. J Virol Methods. 2001 Apr;93(1-2):1-14.

** Jenny-Avital ER, Beatrice ST. Erroneously low or undetectable plasma human immunodeficiency virus type 1 (HIV-1) ribonucleic acid load, determined by polymerase chain reaction, in West African and American patients with non-B subtype HIV-1 infection. Clinical Infect. Dis. 2001 Apr.15; 32(8):1227-30.

Yahi N, Fantini J, Tourres C, Tivoli N, Koch N, Tamalet C. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. J Infect Dis. 2001 May 1;183(9):1311-7.

Vicente AC, Agwale SM, Otsuki K, Njouku OM, Jelpe D, Idoko JA, Caride E, Brindeiro RM, Tanuri A. Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance. Virus Genes. 2001 Mar;22(2):181-6.

Yang JY, Lin TL, Luo CC, Chen HY, Twu SJ. Subtyping HIV-1 infections in Taiwan using peptide-enzyme immunoassay, reverse transcription-polymerase chain reaction, and sequencing. J Formos Med Assoc. 2001 Feb;100(2):89-100.

Perez-Alvarez L, Cuevas MT, Villahermosa ML, Pedreira JD, Manjon N, Herrero I, Lopez-Calvo S, Delgado E, de Parga EV, Medrano L, Thomson MM, Taboada JA, Najera R. Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type 1 in infected individuals in Spain (Galicia). J Hum Virol. 2001 Jan-Feb;4(1):35-8.

Rivera-Morales LG, Novitsky VA, Trujillo JR, Lavalle-Montalvo C, Cano-Dominguez C, Ramos-Jimenez J, Jimenez-Rios E, Flores-Flores L, Lopez-Guillen P, Gilbert P, Vannberg F, Tamez-Guerra R, Rodriguez-Padilla C, Essex M. The molecular epidemiology of HIV type 1 of men in Mexico. AIDS Res Hum Retroviruses. 2001 Jan 1;17(1):87-92.

** Womack C, Roth W, Newman C, Rissing JP, Lovell R, Haburchak D, Essex M, Bond VC. Identification of non-B human immunodeficiency virus type 1 subtypes in rural Georgia. J Infect Dis. 2001 Jan 1;183(1):138-42.

Schmid I, Arrer E, Hawranek T, Patsch W. Evaluation of two commercial procedures for quantification of human immunodeficiency virus type 1 RNA with respect to HIV-1 viral subtype and antiviral treatment. Clin Lab. 2000;46(7-8):355-60.

** Alaeus A. Significance of HIV-1 genetic subtypes. Scand J Infect Dis. 2000;32(5):455-63. Review.

Ortiz M, Munoz L, Bernal A, Rodriguez A, Zorraquino A, Vadillo J, Salas A, Moreno A, Garcia-Saiz A. Molecular characterization of non-B HIV type 1 subtypes from Africa in Spain. AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1967-71.

de Oliveira CF, Diaz RS, Machado DM, Sullivan MT, Finlayson T, Gwinn M, Lackritz EM, Williams AE, Kessler D, Operskalski EA, Mosley JW, Busch MP. Surveillance of HIV-1 genetic subtypes and diversity in the US blood supply. Transfusion. 2000 Nov. 40(11):1399-406.

Barin F, Laperche S, Courouce AM. [Genetic diversity of viruses. Consequences for screening and prevention]. Transfus Clin Biol. 2000 Oct;7(5):472-8. Review. French.

Kellerman S, Wortley P, Fleming P. The Changing Epidemic of HIV. Curr Infect Dis Rep. 2000 Oct;2(5):457-465.

Sharma R. AIDS vaccine research focuses on subtypes in developed world. BMJ. 2000 Sep 30;321(7264):787.

Fonjungo PN, Mpoudi EN, Torimiro JN, Alemnji GA, Eno LT, Nkengasong JN, Gao F, Rayfield M, Folks TM, Pieniazek D, Lal RB. Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon. AIDS Res Hum Retroviruses. 2000 Sep 1;16(13):1319-24.

Pieniazek D, Rayfield M, Hu DJ, Nkengasong J, Wiktor SZ, Downing R, Biryahwaho B, Mastro T, Tanuri A, Soriano V, Lal R, Dondero T. Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group. AIDS. 2000 Jul 28;14(11):1489-95.

O'Shea S, Chrystie I, Cranston R, Mullen J, Corbett K, Murphy G, Parry JV, De Ruiter A, Banatvala J. Problems in the interpretation of HIV-1 viral load assays using commercial reagents. J Med Virol. 2000 Jun;61(2):187-94.

Leandersson AC, Gilljam G, Fredriksson M, Hinkula J, Alaeus A, Lidman K, Albert J, Bratt G, Sandstrom E, Wahren B. Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1. J Virol. 2000 May;74(10):4888-90.

Chaix ML, Manigart O, Letourneur F, Burgard M, Mayaux MJ, Rouzioux C. Diversity of HIV-1 genetic subtypes in France, in the context of mother-to-child transmission. The French Pediatric Cohort Study Group. AIDS. 2000 Feb 18;14(3):327-8.

** Burgisser P, Vernazza P, Flepp M, Boni J, Tomasik Z, Hummel U, Pantaleo G, Schupbach J. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):138-44.

Holodniy M. Viral Load Monitoring in HIV Infection. Curr Infect Dis Rep. 1999 Dec;1(5):497-503.

Peeters M, Delaporte E. [Genetic diversity of HIV infection worldwide and its consequences]. Med Trop (Mars). 1999;59(4 Pt 2):449-55. Review. French.

Takehisa J, Zekeng L, Ido E, Mboudjeka I, Moriyama H, Miura T, Yamashita M, Gurtler LG, Hayami M, Kaptue L. Various types of HIV mixed infections in Cameroon. Virology. 1998 May 25;245(1):1-10.